Articolo su Rivista: [35072] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 16.481 a 16.500 di 35.072
Titolo Data di pubblicazione Autore(i) File
Chronic myeloproliferative diseases: Polycythemia, thrombocythemia, myelofibrosis - Preface 1-gen-2006 Lazzarino, Mario; Cazzola, Mario; Passamonti, Francesco
Molecular characterization of Philadelphia-negative myeloproliferative neoplasms 1-gen-2010 Brisci, Angela; Pietra, Daniela; Foglieni, Barbara; Boggi, Sabrina; Rumi, Elisa; Passamonti, Francesco; Ferrari, Maurizio; Cremonesi, Laura
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 1-gen-2010 Paulli, Marco; Arcaini, L; Lucioni, M; Boveri, E; Capello, D; Passamonti, Francesco; Merli, M; Rattotti, S; Rossi, D; Riboni, R; Berti, E; Magrini, U; Bruno, R; Gaidano, G; Lazzarino, M.
SPLENIC AND NODAL MARGINAL ZONE LYMPHOMAS ARE INDOLENT DISORDERS AT HIGH HEPATITIS C VIRUS SEROPREVALENCE WITH DISTINCT PRESENTING FEATURES BUT SIMILAR MORPHOLOGIC AND PHENOTYPIC PROFILES 1-gen-2004 Arcaini, L; Paulli, Marco; Boveri, E; Vallisa, D; Bernuzzi, P; Orlandi, E; Incardona, P; Brusamolino, E; Passamonti, Francesco; Burcheri, S; Schena, C; Pascutto, C; Cavanna, L; Magrini, U; Lazzarino, M.
EX VIVO MANIPULATION OF HEMATOPOIETIC STEM CELLS FOR TRANSPLANTATION: THE POTENTIAL ROLE OF AMIFOSTINE.SEMINARS IN ONCOLOGY. 1-gen-1999 Balzarotti, M.; Grisanti, S.; Granzow, K.; Saladini, A.; Sala, A.; Nozza, A.; Molteni, A.; Passamonti, Francesco; CARLO STELLA, C.; Santoro, A.; Siena, S.
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA 1-gen-2002 Bernasconi, P.; Boni, M.; Cavigliano, P. M. .; Calatroni, S.; Brusamolino, E.; Passamonti, Francesco; Pistorio, A.; Giardini, I.; Rocca, B.; Caresana, M.; Lazzarino, M.; Brernasconi, C.
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 1-gen-2009 Arcaini, L; Zibellini, S; Passamonti, Francesco; Rattotti, S; Lucioni, M; Invernizzi, R; Merli, M; Rizzi, S; Boveri, E; Rumi, E; Astori, C; Picone, C; Varettoni, M; Pascutto, C; Paulli, Marco; Lazzarino, M.
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment 1-gen-2009 Cervantes, F; Dupriez, B; Pereira, A; Passamonti, Francesco; Reilly, Jt; Morra, E; Vannucchi, Am; Mesa, Ra; Demory, Jl; Barosi, G; Rumi, E; Tefferi, A.
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 1-gen-2008 Boveri, E; Passamonti, Francesco; Rumi, E; Pietra, D; Elena, C; Arcaini, L; Pascutto, C; Castello, A; Cazzola, M; Magrini, U; Lazzarino, M.
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making 1-gen-2005 Malcovati, L; Della Porta, Mg; Pascutto, C; Invernizzi, R; Boni, M; Travaglino, E; Passamonti, Francesco; Arcaini, L; Maffioli, M; Bernasconi, P; Lazzarino, M; Cazzola, M.
Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma 1-gen-2008 Arcaini, L; Montanari, F; Alessandrino, Ep; Tucci, A; Brusamolino, E; Gargantini, L; Cairoli, R; Bernasconi, P; Passamonti, Francesco; Bonfichi, M; Zoli, V; Bottelli, C; Calatroni, S; Troletti, D; Merli, M; Pascutto, C; Majolino, I; Rossi, G; Morra, E; Lazzarino, M.
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 1-gen-2008 Passamonti, Francesco; Rumi, E; Arcaini, L; Boveri, E; Elena, C; Pietra, C; Boggi, S; Astori, C; Bernasconi, P; Varettoni, M; Brusamolino, E; Pascutto, C; Lazzarino, M.
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders 1-gen-2006 Rumi, E; Passamonti, Francesco; Pietra, D; Della Porta, Mg; Arcaini, L; Boggi, S; Elena, C; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, M.
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. 1-gen-2009 Passamonti, Francesco; Rumi, E; Pascutto, C; Cazzola, M; Lazzarino, M.
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference. 1-gen-2009 Barosi, G; Birgegard, G; Finazzi, G; Griesshammer, M; Harrison, C; Hasselbalch, Hc; Kiladjian, Jj; Lengfelder, E; Mcmullin, Mf; Passamonti, Francesco; Reilly, Jt; Vannucchi, Am; Barbui, T.
Survival in young patients with intermediate-/high-risk myelofibrosis: Estimates derived from databases for non transplant patients 1-gen-2009 Siragusa, S; Passamonti, Francesco; Cervantes, F; Tefferi, A.
Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug 1-gen-2004 Passamonti, Francesco; Cazzola, M.
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. 1-gen-2009 Malcovati, L; Della Porta, Mg; Pietra, D; Boveri, E; Pellagatti, A; Gallì, A; Travaglino, E; Brisci, A; Rumi, E; Passamonti, Francesco; Invernizzi, R; Cremonesi, L; Boultwood, J; Wainscoat, Js; Hellström Lindberg, E; Cazzola, M.
New and old prognostic factors in polycythemia vera 1-gen-2009 Passamonti, Francesco
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process 1-gen-2009 Barosi, G; Birgegard, G; Finazzi, G; Griesshammer, M; Harrison, C; Hasselbalch, H; Kiladijan, Jj; Lengfelder, E; Mesa, R; Mc Mullin, Mf; Passamonti, Francesco; Reilly, Jt; Vannucchi, Am; Barbui, T.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 16.481 a 16.500 di 35.072
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • Articoli su Riviste35072
Autore
  • AGENO, WALTER690
  • IACOVIELLO, LICIA598
  • GHEZZI, FABIO505
  • DENTALI, FRANCESCO465
  • ANGELI, FABIO383
  • CASTELNUOVO, PAOLO GIOCONDO MARIA378
  • PIFFARETTI, GABRIELE369
  • PREST, MICHELA357
  • MASCIOCCHI, NORBERTO352
  • DIONIGI, GIANLORENZO340
Data di pubblicazione
  • In corso di stampa25
  • 2020 - 202710392
  • 2010 - 201911782
  • 2000 - 20097850
  • 1990 - 19993601
  • 1980 - 19891162
  • 1970 - 1979252
  • 1967 - 19698
Editore
  • Edizioni Luigi Pozzi Srl:via Pana...51
  • Japadre Editore, L'Aquila36
  • WILEY34
  • Elsevier BV:PO Box 211, 1000 AE A...31
  • ELSEVIER SCIENCE BV29
  • Franco Angeli Riviste SRL:viale M...28
  • Springer Verlag Germany:Tiergarte...28
  • -Roma: [s.n.]. -Artegierre-Esseze...26
  • Elsevier B.V.23
  • Royal Society of Chemistry:Thomas...21
Rivista
  • PHYSICAL REVIEW LETTERS216
  • LA RADIOLOGIA MEDICA180
  • NUCLEAR INSTRUMENTS & METHODS IN ...176
  • ASTRONOMY & ASTROPHYSICS168
  • MONTHLY NOTICES OF THE ROYAL ASTR...165
  • PHYSICS LETTERS. SECTION B154
  • PLOS ONE152
  • SCIENTIFIC REPORTS151
  • THROMBOSIS AND HAEMOSTASIS145
  • IL PROTAGORA140
Serie
  • PROCEEDINGS OF INTERNATIONAL MATH...1
Keyword
  • Humans1605
  • Female801
  • Male679
  • Middle Aged514
  • COVID-19506
  • Aged475
  • Adult453
  • Italy337
  • SARS-CoV-2310
  • Treatment Outcome237
Lingua
  • eng18787
  • ita2905
  • fre60
  • spa55
  • ger35
  • por14
  • bul9
  • rus8
  • gre6
  • chi3
Accesso al fulltext
  • no fulltext24541
  • reserved5244
  • open5084
  • restricted107
  • partially open93
  • mixed2
  • embargoed1